MA1081

Hepatitis B Virus X Monoclonal Antibody (X36C), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 MA1081-Each-of-1 In Stock ₹ 46,324.50

MA1081 - Each of 1

₹ 46,324.50

In Stock

Quantity

1

Base Price: ₹ 46,324.50

GST (18%): ₹ 8,338.41

Total Price: ₹ 54,662.91

Antigen

Hepatitis B Virus X

Classification

Monoclonal

Concentration

1 mg/mL

Formulation

PBS with 0.05% sodium azide

Host Species

Mouse

Purification Method

HPLC

Regulatory Status

RUO

Target Species

Virus

Product Type

Antibody

Isotype

IgG1

Applications

ELISA, Immunoprecipitation, Western Blot

Clone

X36C

Conjugate

Unconjugated

Gene Alias

HBV; HBVgp3; HepB; HepB X

Immunogen

Baculovirus expressed recombinant HBx.

Quantity

100 μg

Primary or Secondary

Primary

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Related Products

Img

Thermo Scientific

MA1080

--

Img

Thermo Scientific

MA171514

--

Img

Thermo Scientific

MA171503

--

Img

Thermo Scientific

MA121697

--

Img

Thermo Scientific

MA120275

--

Img

Thermo Scientific

MA171509

--

Img

Thermo Scientific

MA171512

--

Img

Thermo Scientific

MA171513

--

Description

  • MA1-081 detects hepatitis B x (HBx) protein from transfected human cells
  • MA1-081 has been successfully used in Western blot, immunoprecipitation and ELISA procedures
  • By Western blot, this antibody detects a single ∽17 kDa protein representing HBx
  • This antibody is not capable of immunoprecipitating HBx complexed with HBx interacting protein (XIP)
  • The MA1-081 immunogen is baculovirus expressed recombinant HBx
  • The hepatitis B virus is an important cause of acute and chronic liver disease
  • It is also the most common form of parenterally transmitted viral hepatitis
  • The Hepatitis B X antigen is a 154 amino acid ∽17 kDa multifunctional protein involved in the development of liver chirrosis and hepatocellular carcinoma
  • The virus is estimated to affect some 350 million people worldwide
  • Immunization against hepatitis B is an important component of preventative medicine and is offered to all children in approximately 30 countries
  • Hepatitis B virus (HBV) belongs to the Hepadnaviridae family and infection with HBV is usually more serious than infection with hepatitis A virus
  • In some individuals the infection is not cleared and followed by persistent intracellular viral carriage that can lead to the development of hepatocelular carcinomas
  • There are currently 400 million HBV carriers worldwide making HBV one of the most common human pathogens.